Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Kirk Randal J
Relationship:   10% Owner
City:   Radford
State:   VA
   
Insider Summary:
  
   
Companies Owned :   6    
Direct Shares   3,684,697    

Indirect Shares

   67,796,291      
Direct Value   $186,689,752    

Indirect Value

   $435,109,863      
Total Shares   71,480,988      
Total Value   $621,799,616      


Halozyme Therapeutics Inc $186,669,131 Alaunos Therapeutics $20,621 Halozyme Therapeutics Inc $186,669,131 Alaunos Therapeutics $20,621
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    14   
    0    

     Stock price went up :
    7   
    0    
     Stock price went down :
    7   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
   47.2%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Clinical Data Inc CLDA Director, 10% Owner 2011-04-12 0 2011-04-12 0    Premium*  
            Halozyme Therapeutics Inc HALO 10% Owner 2018-08-28 3,562,388 2018-08-28 6,629,464    Premium*  
            Precipio Inc PRPO 10% Owner 2012-02-03 0 2018-08-28 27,151    Premium*  
            Precigen Inc PGEN 0 2024-05-02 51,557,665    Premium*  
            Alaunos Therapeutics TCRT Director, 10% Owner 2015-12-31 122,309 2015-12-31 9,570,094    Premium*  
            Aquabounty Technologies, Inc. AQB 10% Owner 2020-02-13 0 2020-12-17 11,917    Premium*  
* Premium Members only  

Records found :    271         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 4 of 11
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
PGEN Precigen Inc Chief Executive Officer   •       •       •   2016-08-31 4 A $25.24 $999,971 I/I 35,509 5,267,327 0 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2016-09-30 4 A $27.44 $999,965 I/I 36,291 5,274,464 0 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2016-01-29 4 A $27.11 $999,977 I/I 36,372 78,187 0 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2016-12-30 4 A $24.30 $999,964 I/I 36,418 5,297,210 0 -
HALO Halozyme Therapeutics Inc Director   –       •       •   2008-06-18 4 B $5.76 $212,124 I/I 36,827 322,791 2.25 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2016-10-31 4 A $26.10 $999,978 I/I 37,647 5,282,126 0 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2019-03-29 4 A $5.26 $199,996 I/I 38,022 16,146,867 0 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2016-05-31 4 A $24.35 $999,989 I/I 39,360 4,896,818 0 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2016-06-30 4 A $24.61 $999,967 I/I 39,498 5,239,681 0 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2016-07-29 4 A $24.55 $999,967 I/I 40,481 5,247,576 0 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2017-05-31 4 A $21.32 $999,961 I/I 40,544 5,344,511 0 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2017-01-31 4 A $21.16 $999,980 I/I 41,748 5,306,661 0 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2016-05-13 4 B $23.92 $1,000,574 I/I 41,830 6,649,997 2.64 -
CLDA Clinical Data Inc Director   –       •       •   2006-09-06 4 B $14.95 $627,900 I/I 42,000 612,263 2.25 -
HALO Halozyme Therapeutics Inc Director   –       •       •   2008-06-17 4 B $5.98 $251,160 I/I 42,000 285,964 2.25 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2017-06-30 4 A $22.82 $999,973 I/I 43,358 5,352,813 0 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2017-07-31 4 A $21.59 $999,985 I/I 43,850 13,461,314 0 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2019-04-30 4 A $4.56 $200,125 I/I 43,887 16,190,754 0 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2019-05-31 4 A $4.52 $200,159 I/I 44,283 17,946,829 0 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2019-06-04 4 B $5.17 $233,270 I/I 45,120 1,078,323 2.64 -
PGEN Precigen Inc Executive Chairman   •       •       •   2020-02-28 4 A $4.39 $200,057 I/I 45,571 22,730,215 0 -
HALO Halozyme Therapeutics Inc Director   –       •       •   2008-06-13 4 B $5.53 $252,859 I/I 45,725 218,164 2.25 -
HALO Halozyme Therapeutics Inc 10% Owner   –       –       •   2007-03-13 4 B $7.93 $365,414 I/I 46,080 1,308,080 1.5 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2017-03-31 4 A $19.82 $999,980 I/I 47,897 5,325,535 0 -
HALO Halozyme Therapeutics Inc 10% Owner   –       –       •   2018-07-27 4 S $16.90 $826,866 I/I (48,927) 3,616,655 0 -
  271  Records found
  1   2   3   4  5   6   7   8   9   10   11      
  Page 4 of 11  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us